Develops off-the-shelf CAR-NK cell therapies using synthetic biology to treat a wide range of cancers, including solid tumors.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Catamaran Bio is developing novel, off-the-shelf CAR-NK cell therapies designed to treat a broad range of cancers, including solid tumors. Our proprietary capabilities enable us to harness the natural cancer-fighting properties of NK cells and enhance and tailor their effectiveness with the power of synthetic biology and innovative non-viral cell engineering.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Catamaran Bio Management Team
Investors
Astellas Venture Management LLC
Lightstone Ventures
Sofinnova Partners SAS
SV Health Investors, LLC
Takeda Ventures, Inc.
Catamaran Bio Valuations & Financials
View real-time NPM data on Catamaran Bio stock including daily Catamaran Bio stock price estimates, valuation history, and historical share price information. Access Catamaran Bio financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Catamaran Bio pricing across six independent market signals. Looking for private company due diligence data sources on Catamaran Bio? Get in touch to learn more.
Similar Companies
like Catamaran Bio
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Boost Biomes
Climate & Sustainability
Engineers microbial communities to boost crop health, yields and post-harvest longevity.
Volt SAS
Climate & Sustainability
Provides utility-scale solar energy solutions that integrate clean power delivery with community-focused environmental and equity initiatives.
Athos Therapeutics
Healthcare & Life Sciences
Develop therapies that leverage AI and omics data to target inflammatory and autoimmune diseases with precision small molecules.
BookNook
Consumer
Delivers live, research-based reading and math tutoring for K–8 students through an online platform in partnership with schools.
SweetLabs
Enterprise Software
Delivers app distribution that enables developers and device makers to recommend and monetize apps via dynamic, connected platforms.
Josh.ai
AI & Machine Learning
Develops AI-powered smart home systems for voice and app-based control of lighting, climate, security, and entertainment.
Endless West
Consumer
Molecular science company creates custom spirits and concentrates for beverage brands, offering sustainable and cost-effective production solutions.
Zencity
Enterprise Software
AI-powered platform helps local governments analyze community data and feedback to make better decisions for public services and safety.
FAQ
We have answers
Catamaran Bio stock does not trade on public stock exchanges. Catamaran Bio stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Catamaran Bio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Catamaran Bio Stock does not trade on public stock exchanges. In order to sell Catamaran Bio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Catamaran Bio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Catamaran Bio share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Catamaran Bio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Catamaran Bio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Catamaran Bio stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Catamaran Bio is a private company and has not had an IPO. There is currently no Catamaran Bio IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Catamaran Bio IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
